ArticleNature communications2025

EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers.

Marija Maric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.